Abstract
Annals of NeurologyVolume 49, Issue 3 p. 285-287 Editorial The neurochemistry of therapeutics: Levodopa pharmacodynamics in Parkinson's disease Kirk A. Frey MD, PhD, Kirk A. Frey MD, PhD Departments of Radiology (Division of Nuclear Medicine) and Neurology, University of Michigan, Ann Arbor, MISearch for more papers by this author Kirk A. Frey MD, PhD, Kirk A. Frey MD, PhD Departments of Radiology (Division of Nuclear Medicine) and Neurology, University of Michigan, Ann Arbor, MISearch for more papers by this author First published: 01 March 2001 https://doi.org/10.1002/ana.62Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume49, Issue31 March 2001Pages 285-287 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
